(Q31029459)

English

Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 June 2017

Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis (English)

1 reference

Europe PubMed Central

28 June 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Kragballe K

1

1 reference

Europe PubMed Central

28 June 2017

van de Kerkhof PC

2

1 reference

Europe PubMed Central

28 June 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

28 June 2017

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

28 June 2017

20

1 reference

Europe PubMed Central

28 June 2017

1

1 reference

Europe PubMed Central

28 June 2017

39-44

1 reference

Europe PubMed Central

28 June 2017

Treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01343.X

21 January 2018

Psoriasis causes as much disability as other major medical diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01343.X

21 January 2018

A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01343.X

21 January 2018

Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical tria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01343.X

21 January 2018

Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01343.X

21 January 2018

A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01343.X

21 January 2018

Identifiers

10.1111/J.1468-3083.2005.01343.X

1 reference

Europe PubMed Central

28 June 2017

1 reference

Europe PubMed Central

28 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31029459&oldid=1953773031"